PROVIDENCE, R.I. (AP) — A federal judge has ruled that the recent mass layoffs at the U.S. Health and Human Services were ...

Despite remarkable progress over the past 20 years in expanding HIV testing and treatment services globally, adolescents continue to lag behind adults in making progress towards epidemic control, ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

These guidelines are a significant improvement over current HIV testing practices in healthcare settings, ... CDC Recommends Universal, Routine HIV Screening for Adults - Medscape - Oct 01, 2006.

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Introduction HIV continues to have great impact on millions of lives. Novel methods are needed to disrupt HIV transmission networks. In the USA, public health departments routinely conduct contact ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

PURPOSE 1 tracked over 5,000 cisgender women in South Africa and Uganda starting in 2021. Not a single woman who received lenacapavir contracted HIV over the course of the trial .